Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-273-1 | CAS number: 102089-74-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Based on the results from the chromosome aberration, AMES, and in vitro mammalian cell gene mutation tests there was no indication of genetic toxicity.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24th September 2018 to 29th October 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Qualifier:
- according to guideline
- Guideline:
- other: PRC-MEP, The Guidelines for the Testing of Chemicals (Health Effect, 2nd Edition), 476 'In vitro Mammalian Cell Mutation Tests (2013)
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian cell gene mutation tests using the thymidine kinase gene
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: TK± (3.7.2C0)
For cell lines:
- Absence of Mycoplasma contamination: Affirmed
- Periodically ‘cleansed’ of spontaneous mutants: Yes
MEDIA USED
- Type and composition of media: RPMI1640 plus horse serum (1-20%), Penicillin-Streptomycin 1% and sodium pyruvate 2%.
- CO2 concentration: 4-5%
humidity level,
- Temperature: 35.6 - 37.3 oC - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat liver S9 prepared in-house
- Test concentrations with justification for top dose:
- In a preliminary test, the cells were exposed to 2000, 400, 80, 16 and 3.2 µg/ml for 3 and 24 hours with and without metabolic activity. The results showed that 2000 and 400 µg/ml had precipitation at the beginning and end of the test. There was no test item precipitation observed in the other doses.
Six exposure concentrations of 2000, 667, 222, 74, 25 and 8.2 µg/ml were chosen for the definitive test. - Vehicle / solvent:
- Dimethylsulfoxide (DMSO)
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- methylmethanesulfonate
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments: 3
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 6 x 10 5
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 3 hours with metabolic treatment, 3 hours without metabolic treatment, 3 hours without metabolic treatment
FOR GENE MUTATION:
- Expression time (cells in growth medium between treatment and selection): 24 hours
- Method used: microwell plates for the mouse lymphoma assay.
- Selective agent: Trifluorothymidine (TFM), 3ug/ml, incubated for 11 days.
- Number of cells seeded and method to enumerate numbers of viable and mutants cells: 0.2ml of cell culture.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: relative total growth (RTG)
METHODS FOR MEASUREMENTS OF GENOTOXICIY
Mutant frequency (MF) - Evaluation criteria:
- When the IMF (Induced Mutant Frequency) at one or several doses is more than 126 x 10 6 and the increase is concentration related and can be replicated, the result is evaluated as positive.
If this criteria is not met, the result is evaluated as negative.
The increase is dose-related or reproducible. - Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- The RTG of the cells exposed for 3 hours in the absence of S9 mix at the doses of 10, 4, 1.6, 0.64, 0.26 and 0.1μg/ml were 25%, 37%, 60%, 96%, 90% and 91%. The RTG of the cells exposed for 3 hours in the presence of S9 mix at the doses of 10, 4, 1.6, 0.64, 0.26 and 0.1 μg/ml were 38%, 45%, 56%, 76%, 105% and 107%.The RTG of the cells exposed for 24 hours in the absence of S9 mix at the doses of 10, 4, 1.6, 0.64, 0.26 and 0.1 μg/ml were 34%, 53%, 61%, 81%, 76% and 80%.
The results of mutant frequency showed that the IMF of all cells cultures at all doses exposed for 3 and 24 hours in the presence and absence of S9 were less than 126 x 106. - Conclusions:
- It can be concluded that the test item Boc-phenyl glycinol is non-mutagenic to the L5178Y mouse lymphona cells under the test conditions of this study.
- Executive summary:
This study was performed to evaluate Boc-phenyl Glycinol for its ability to cause gene mutations in vitro in cultured mammalian cells after being exposed for 3 hours with and without metabolic action and for 24 hours without metabolic action. The test method was designed to be compatible with OECD Guideline No. 490 'In vitro Cell Gene Mutation tests using the Thymidine Kinase Gene' (July 29, 2016).
The mouse lymphona L5178Y (TK± (3.7.2C0)) cells were exposed to six exposure concentrations, 2000, 667, 222, 74, 25 and 8.2 µg/ml at the treatment conditions outlined above. The positive and solvent (DMSO) controls were included at the same time. Plating Efficiency (PE) of the cells after expression was determined and the relative total growth (RTG) was calculated to evaluate cytotoxicity. The mutant frequency (MF) and the induced mutant frequency (IMF) above solvent control of each culture, the induced mutant frequency of small clones (IMFsc) of the highest evaluatable concentration and all controls were determined after selection with 5-tri-fluorothymidine (TFT). For the determination of cloning efficiency as well as the selection of mutants, the microwell technoique was applied.
In this test, the results of the solvent and positive controls met all quality criteria, so the sensitivity of the assay and the efficacy of the S9 mix could be validated. In the cell cultures of the definitive test series, 2000 and 667 µg/ml had precipitation at the beginning and end of the test. There was no test item precipitation observed at any of the remaining test concentrations either at the beginning or the end of the treatment.
The cytotoxicity results were as follows: The RTG of the cells exposed for 3 hours in the absence of S9 mix at doses of 2000, 667, 222, 74, 25 and 8.2 µg/ml were 11.53%, 35.89%, 73.47%, 86.16%, 73.71% and 91.29% respectively. The RTG of the cells exposed for 3 hours in the presence of S9 mix at doses of 2000, 667, 222, 74, 25 and 8.2 µg/ml were 11.12%, 52.50%, 89.40%, 80.87%, 89.05% and 97.59% respectively. The RTG of the cells exposed for 24 hours in the absence of S9 mix at doses of 2000, 667, 222, 74, 25 and 8.2 µg/ml were 3.3%, 13.18%, 73.27%, 87.82%, 86.28% and 83.02% respectively.
The results of mutant frequency showed that the induced mutant frequency of all cultures exposed for 3 and 24 hours were consistently less than the average background mutant frequency of 126 x 10-6.
The results of this study are negative, so it can be concluded that the test item Boc-phenyl glycinol is non-mutagenic to the L5178Y mouse lymphona cells under the test conditions of this study.
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 20 2016 to July 15 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- The Guidelines for the Testing of Chemicals Health Effects
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535
- Species / strain / cell type:
- other: S. typhimurium TA 97a
- Species / strain / cell type:
- S. typhimurium TA 98
- Species / strain / cell type:
- S. typhimurium TA 100
- Species / strain / cell type:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Metabolic activation system:
- Source: Research Institute for Liver Diseases (Shanghai) Co, LTD
Treatment: Metabolic activation system was prepared from the livers of male SD rat inducing by PCBs (Aroclor 1254)
Storage: stored at -80C
Before the used, made S9 and coenzyme system (S9 mixture). - Test concentrations with justification for top dose:
- Based on the prelimary experiment, the doses of this test were 156, 312, 625, 1250, and 2500ug/plate. Blank control, solvent control (dimethylsulfoxide) and positive control had been included. Triplicate cultures were made per dose in the test.
- Vehicle / solvent:
- Dimethylsulfoxide
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- other: sodium p (dimethylamino)benzenediazo sulfonate, methyl sulfonic acid methyl ester, cyclophosphamide, 2-aminofluorene
- Evaluation criteria:
- A test substance is deemed to provide evidence of mutagenic potential if a significant dose-related increase in the number of revertant colonies is obtained in two separate experiments, and the increase in the number of revertant colonies is at least twice the concurrent solvent control group value.
The test substance should be detected by five strains. as long as there is a test strain, either with S9 or without S9 is positive, can determine the test sample is positive in Ames Test.
According to the guidelines of OECD471 if the test results are negative or questionable results it should be repeated. In this test, formal test results were negative, so the test was repeated. - Key result
- Species / strain:
- other: TA97a, TA98, TA100, TA102, TA1535
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- other: TA97a, TA98, TA100, TA102, TA1535
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- no mutagenic potential (based on QSAR/QSPR prediction)
- Conclusions:
- Based on the test results, under the current test conditions, N-Boc-D-phenylglycinol is not mutagenic in the tester strains TA97a, TA98, TA100, TA102, and TA1535.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 07 2016 to July 05 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster lung (CHL/IU)
- Details on mammalian cell type (if applicable):
- Source: Cell Bank of the Preservation Committee for Typical Cultures, Chinese Academy of Sciences.
Culture Media: Roswell Park Memorial Institute Medium 1640
Culture Conditions: The cells were cultured in an incubator at 37C with 5% CO2 concentration. - Metabolic activation:
- with and without
- Metabolic activation system:
- Source: Research Institute for Liver Diseases Co Ltd.
Treatment: Metabolic Activation system was prepared from the livers of male SD rats induced by polychlorinated benzenes - Test concentrations with justification for top dose:
- Based on the result of the preparatory test, the IC50 value of N-Boc-D-phenylglycinol was determined to be 0.38mg/mL, the IC50 value is used as the highest dose and the other rates were set at the 1/2 and 1/4 of the highest dose level according to the generally accepted procedures for in Vitro Mammalian Chromosome Aberration Test such as OECD guideline 473. Therefore the dosages used in this test were 0.38mg/mL, 0.19mg/mL, and 0.095mg/mL respectively.
- Vehicle / solvent:
- DMSO (dimethylsulfoxide)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Evaluation criteria:
- At least one of the test concentrations exhibits a statistically signifigant increase compared with the concurrent negative control. The difference between the exposure group and the control group had used the chi square test to evaluate it whether has statistically signifigant.
- Key result
- Species / strain:
- Chinese hamster lung (CHL/IU)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- The induced chromosome aberration rates of the CHL cells with metabolic activation system (S9), after 6 hours treatment by N-Boc-D-Phenylglycinol at a dose of 0.38, 0.19, and 0.095 mg/ml, were determined to be 1.67%, 1.00%, and 1.33%; and 1.00&, 1.00%, and 0.67% respectively after 6 hours of treatment without metabolic activation system (S9); and 2.67%, 2.00%, and 1.67% respectively after 24 hours treatment without the metabolic activation system (S9). Compared with the negative control groups, there was no statistically signifigant difference observed (P>0.05). The chromosome aberrations rate excluding the gap of the positive control group was determined to be 19.00% for the 6 hours of treatment with metabolic activation system(S9); 23.00% for the treatment of 6 hours without metabolic activation system (S9); and 27.33% for the treatment of 24 hours without metabolic activation system (S9), respectively. Compared with the negative control group, there was statistically signifigant difference observed (P<0.05).
- Remarks on result:
- no mutagenic potential (based on QSAR/QSPR prediction)
- Conclusions:
- Based on the test results, under the current test conditions, N-Boc-D-Phenylglycinol does not induce chromosome aberration in cultured Chinese Hamster Lung Fibroblast cells (CHL) both with and without metabolic activation system.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.